跳至主要内容
临床试验/NCT06227208
NCT06227208已完成不适用

The Impact of Postoperative Opioids on Duration and Severity of Desaturation and Bradypnea in Opioid-naïve and Chronic Opioid Patients, Assessed by Continuous Vital Sign Monitoring.

Rigshospitalet, Denmark2 个研究点 分布在 1 个国家目标入组 691 人开始时间: 2023年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
691
试验地点
2
主要终点
SpO2 <88% in the four hours following opioid administration

研究概览

简要总结

Aim: To describe the duration of desaturation and bradypnea in postoperative opioid-naïve and chronic opioid patients. Patients: 691 patients included from two previous WARD (Wireless Assessment of Respiratory and circulatory Distress) projects. Outcome: Respiratory deviations four hours after opioid administration

详细描述

Aim: To describe the duration of desaturation and bradypnea in postoperative opioid-naïve and chronic opioid patients within the first four hours following opioid administration in addition to the chronic dose, using a continuously wireless monitoring system.

Patients: 691 patients included from two previous WARD (Wireless Assessment of Respiratory and circulatory Distress) projects. Continuous wireless monitoring data of peripheral tissue oxygenation (SpO2) and respiratory rate (RR) was conducted in postoperative patients. Data were stratified into opioid-naïve and chronic opioid patients, based on their preoperative opioid history. Patients who did not receive opioids postoperatively were served as the control group. Data was evaluated one hour before and four hours after opioid administration. The primary outcome was the cumulative duration of SpO2 <88%.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients from studies WARD Surgery Observational [gov: NCT03491137]
  • The control group from WARD Surgery Randomized Controlled Trial [gov: NCT04640415]

排除标准

  • Less than 30 minutes of continuous monitoring data within the 60-minute window prior to opioid administration
  • Less than 120 minutes (<50% of theoretical maximum) of monitoring data available during the four-hour observation period
  • Patients who received transdermal fentanyl as postoperative opioid
  • Patients with a baseline saturation or respiratory rate below the prespecified thresholds
  • Patients with a BMI of ≥40 or diagnosed with COPD were excluded in the analysis of SpO2 <92%

结局指标

主要结局

SpO2 <88% in the four hours following opioid administration

时间窗: four hours following opioid administration

次要结局

  • Respiratory deviations four hours after opioid administration(four hours following opioid administration)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eske Kvanner Aasvang

Professor, head of research, MD, DmSci

Rigshospitalet, Denmark

研究点 (2)

Loading locations...

相似试验